Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis

Medical Science Monitor

Volumn 10, Issue 4, 2004, Pages

  Jośko, Jadwiga ^a   Mazurek, Michał ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Angiogenesis; Transcription factors; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOPOIETIN; ANGIOTENSIN; ANTIESTROGEN; E1A PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; LEAD; LEUKEMIA INHIBITORY FACTOR; MERSALYL; MIFEPRISTONE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROSTAGLANDIN DERIVATIVE; RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ADRENERGIC SYSTEM; ANGIOGENESIS; DNA RESPONSIVE ELEMENT; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE THERAPY; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; ONCOGENE; ONCOGENE SRC; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVIEW; STOMACH ULCER; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ANGIOTENSIN II; CYTOKINES; GENE EXPRESSION REGULATION; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; ONCOGENES; PROSTAGLANDINS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 1942502894     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Carmeliet P, Collen D: Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr. Top. Microbiol. Immunol, 1999; 237: 133-58
2. Semenza GL: Hypoxia-inducible factor 1: master regulator of O(2) homeostasis. Curr Opin Genet Dev, 1998; 8: 588-94
3. Jiang BH, Rue E, Wang GL et al: Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem, 1996; 271: 17771-78
4. Martin C, Yu AY, Jiang BH et al: Cardiac hypertrophy in chronically anemic fetal sheep: increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am J Obstet Gynecol, 1998; 178: 527-34
5. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol, 1992; 12: 5447-54
6. Semenza GL, Jiang BH, Leung SW et al: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem, 1996; 271: 32529-37
7. Jiang BH, Zheng JZ, Leung SW et al: Transactivation and inhibitory domains of hypoxia-inducible factor 1(alpha): modulation of transcriptional activity by oxygen tension. J Biol Chem, 1997; 272: 19253-60
8. Wood SM, Gleadle JM, Pugh CW et al: The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression: studies in ARNT-deficient cells. J Biol Chem, 1996; 271: 15117-23
9. Jiang BH, Semenza GL, Bauer C, Marti HH: Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am-J-Physiol, 1996; 271: 1172-80
10. Lee SH, Wolf PL, Escudero R et al: Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med, 2000; 342: 626-33
11. Kimura H, Weisz A, Kurashima Y et al: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood, 2000; 95: 189-97
12. Blancher C, Moore JW, Talks KL et al: Relationship of HIF-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res, 2000; 60: 7106-13
13. Elvert G, Lanz S, Kappel A, Flamme I: mRNA cloning and expression studies of the quail homologue of HIF-2α. Mech Dev, 1999; 87: 193-97
14. Ema M, Taya S, Yokotani N et al: A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA, 1997; 94: 4273-78
15. Akeno N, Czyżyk-Krzeska MF, Gross TS, Clemens TL: Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2α. Endocrinology, 2001; 142: 959-62
16. Flamme I, Frohlich T, von-Reutern M et al: HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels. Mech Dev, 1997; 63: 51-60
17. Kimura H, Weisz A, Ogura T et al: Identification of Hypoxia-inducible Factor 1 Ancillary Sequence and its Function in Vascular Endothelial Growth Factor Gene Induction by Hypoxia and Nitric Oxide J Biol Chem, 2001; 276: 2292-98
18. May MJ, Ghosh S: Signal transduction through NF-κB. Immunol Today, 1998; 2: 80-88
19. Moeller JM, Rupec RA, Baeuerele PA: Study of gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods, 1997; 11: 301-12
20. Shibata A, Nagaja T, Imai T et al: Inhibition of NF-κB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat, 2002; 73: 237-43
21. Okamoto T, Yamagishi S, Inagaki Y et al: Angiogenesis is induced by advanced glycation end products and its prevention by cervistatin. FASEB J, 2002; 16: 1928-30
22. Hirota K, Matsui M, Iwata S et al: AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA, 1997; 94: 3633-38
23. Damert A, Ikeda E, Risau W: Activator-protein-1 binding potentiates the HIF-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J, 1997; 327: 419-23
24. Finkenzeller G, Technau A, Marme D: Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun, 1995; 208: 432-39
25. Salnikow K, Kluz T, Costa M et al: The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol, 2002; 22: 173441
26. Pal S, Claffey KP, Cohen HT, Mukhopadhyay D: Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J Biol Chem, 1998; 273: 26277-80
27. Shi Q, Le X, Abbruzzese JL et al: Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res, 2001; 61: 4143-54
28. Szabo S, Khomenko T, Gombos Z et al: Review article: transcription factors and growth factors in ulcer healing. Aliment Pharmacol Ther, 2000; 14: 33-43
29. Jones MK, Kawanaka H, Baatar D et al: Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology, 2001; 121: 1040-47
30. Hyder SM, Huang JC, Nawaz Z et al: Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect, 2000; 108: 5785-90
31. Jośko J, Hendryk S, Jȩdrzejowska-Szypułka H et al: Effect of phosphoramidon on brain tissue angiogenesis in the chronic phase of vasospasm after subarachnoid hemorrhage in the rat. Med Sci Moni, 2001; 7: 1182-87
32. Laughner E, Taghavi P, Chiles K et al: HER2(neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression. Mol Cell Biol, 2001; 21: 3995-4004
33. Fukumura D, Gohongi T, Kadambi A, et al.: Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA, 2001; 98: 2604-9
34. Tanaka T, Kanai H, Sekiguchi K et al: Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol, 2000; 32: 1955-67
35. Gille J, Swerlick RA, Caughman SW: Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J, 1997; 16: 750-59
36. Sanchez-Elsner T, Botella LM, Velasco B et al: Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem, 2001; 276: 38527-35
37. Albina JE, Mastrofrancesco B, Vessella JA et al: HIF-1 expression in healing wounds: HIF-1α induction in primary inflammatory cells by TNF-α. Am J Physiol Cell Physiol, 2001; 281: 1971-77
38. Hossain MA, Bouton CM, Pevsner J, Laterra J: Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway. J Biol Chem, 2000; 275: 27874-82
39. Bamba H, Ota S, Kato A et al: Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. Biochem Biophys Res Commun, 2000; 273: 485-91
40. Zelzer E, Levy Y, Kahana C et al: Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α /ARNT. EMBO J, 1998; 17: 5085-94
41. Feldser D, Agani F, Iyer NV et al: Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res, 1999; 59: 3915-18
42. Treins C, Giorgetti-Peraldi S, Murdaca J, Van-Obberghen E: Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem, 2001; 276: 43836-41
43. Inoue M, Itoh H, Tanaka T et al: Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol, 2001; 21: 560-66
44. Maeno T, Tanaka T, Sando Y et al: Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Am J Respir Cell Mol Biol, 2002; 26: 246-53
45. Gille J, Reisinger K, Asbe-Vollkopf A et al: Ultraviolet-A-induced transactivation of the vascular endothelial growth factor gene in HaCaT keratinocytes is conveyed by activator protein-2 transcription factor. J Invest Dermatol, 2000; 115: 30-36
46. Mori K, Tani M, Kamata K et al: Mitogen-activated protein kinase, ERK 1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells. Free Radic Res, 2000; 33: 157-66
47. Chua CC, Hamdy RC, Chua BH: Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta, 1998; 1401: 187-94
48. Agani F, Semenza GL: Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. Mol Pharmacol, 1998; 54: 749-54
49. Funamoto M, Fujio Y, Kunisada K et al: Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem, 2000; 275: 10561-66
50. Asano A, Irie Y, Saito M: Isoform-specific regulation of vascular endothelial growth factor (VEGF) family mRNA expression in cultured mouse brown adipocytes. Mol Cell Endocrinol, 2001; 174: 71-76
51. Fidler IJ, Ellis ML: The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell, 1994; 79: 185-88
52. Osiecka BJ, Ziółkowski P, Gamian E et al: Determination of Vascular-Endothelial Growth Factor in serum from tumor-bearing BALB/c mice treated with photodynamic therapy. Med Sci Monit, 2003; 9(4): 150-54
53. Richard DE, Berra E, Pouyssegur J: Nonhypoxic pathway mediates the induction of hypoxia inducible factor 1αa in vascular smooth muscle cells. J Biol Chem, 2000. 275: 26765-71
54. Cockman ME, Masson N, Mole DR et al: HIF-1-α binding and ubiquitination by the von Hippel-Lindau tumor suppressor protein. J Biol Chem, 2000; 275: 2573341
55. Richard DE, Berra E, Gothie E et al: p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J Biol Chem, 1999; 274: 32631-37
56. Mukhopadhyay D, Knebelmann B, Cohen HT et al: The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol, 1997; 17: 5629-39
57. Flamme I, Krieg M, Plate KH: Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2α. Am J Pathol, 1998; 153: 25-29
58. Jiang BH, Agani F, Passaniti A, Semenza GL: V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res, 1997; 57: 5328-35
59. Boyd J, Loewenstein PM, Tang Q et al: The adenovirus 2 EIA N-terminal domain sequence requirements for repression of transcription in vitro and in vivo correlate with those required for EIA interference with TBP/TATA complex formation. J Virol, 2002; 76: 1461-74
60. Kumaravel S, Wafik S: Inhibition of p53-mediated transactivation and cell cycle arrest hy EIA through its p300/CBP-interacting region. Oncogene, 1999; 14: 1047-57
61. Tsang SX, Morris GF, Lu M, Morris CB: TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus EIA 243R oncoprotein. Oncogene, 1996; 12: 819-26
62. Arany Z, Huang LE, Eckner R et al: An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA, 1996; 93: 12969-73
63. Sodhi A, Montaner S, Patel V et al: The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res, 2000; 60: 4873-80
64. Drissi H, Luc Q, Shakoori R et al: Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol, 2000; 184: 341-50
65. Choi JY, Pratap J, Javed A, et al: Sobnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci USA, 2001; 98: 8650-55
66. Zelzer E, Glotzer DJ, Hartmann C et al: Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev, 2001; 106: 97-106
67. Fernandez A, Udagawa T, Schwesinger C et al: Angiogenic Potential of Prostate Carcinoma Cells Overexpressing bcl-2. J Nation Cancer Institute, 2001; 93: 208-13
68. Rebar EJ, Huang Y, Hickey R et al: Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med, 2002; 8: 1427-32